Litcius/Paper detail

Tranexamic Acid for the Prevention of Blood Loss After Cesarean Delivery

Loı̈c Sentilhes, Marie Victoire Sénat, Maëla Le Lous, Norbert Winer, Patrick Rozenberg, Gilles Kayem, Éric Verspyck, Florent Fuchs, Élie Azria, Denis Gallot, Diane Korb, Raoul Desbrière, Camille Le Ray, Céline Chauleur, Fanny De Marcillac, F. Perrotin, Olivier Parant, Laurent Salomon, Emilie Gauchotte, Florence Bretelle, N. Sananès, Caroline Bohec, Nicolas Mottet, Guillaume Legendre, V. Letouzey, Bassam Haddad, Delphine Vardon, Hugo Madar, Aurélien Mattuizzi, Valérie Daniel, Sophie Regueme, Caroline Roussillon, Antoine Bénard, Aurore Georget, Astrid Darsonval, Catherine Deneux‐Tharaux, for the Groupe de Recherche en Obstétrique et Gynécologie

2021Obstetrical & Gynecological Survey25 citationsDOI

Abstract

(Abstracted from N Engl J Med 2021;384:1623–1634) Uterotonic agents are recommended to prevent postpartum hemorrhage (PPH). Tranexamic acid (TXA) has emerged as another medical approach to prevent blood loss after delivery.

Topics & Concepts

UterotonicMedicineTranexamic acidBlood lossCesarean deliveryObstetricsAnesthesiaOxytocinPregnancySurgeryInternal medicineGeneticsBiologyMaternal and fetal healthcareBlood transfusion and managementPregnancy and preeclampsia studies